logo-loader
viewNabis Holdings Inc.

Nabis Holdings in joint venture with Israeli pharmaceutical company Panaxia

The joint venture is to launch multiple pharma-grade THC and CBD cannabis products in Arizona in the second half of 2020

Nabis Holdings Inc. - Nabis Holdings forges joint venture with Israeli pharmaceutical company Panaxia
The pharma grade THC and CBD cannabis products will be produced in Nabis Holdings' large Camp Verde facility in Arizona

Nabis Holdings Inc (CSE:NAB) (OTCMKTS:NABIF), a Canadian cannabis investment company, revealed Tuesday that it has struck a binding memorandum of understanding with Panaxia Pharmaceutical Industries Ltd, the largest medical cannabis products maker in Israel. 

Under the terms of the pact, Panaxia will provide proprietary pharma-grade cannabis-based products that have proven to be in high demand in other states in the US, including New Mexico, Colorado and California. The products will be produced in the first operating EU GMP facility in Arizona, under Nabis licenses. It is located at the company’s 44,000 square foot cultivation, production and fulfillment facility in Camp Verde in Arizona. 

Nabis will provide the raw materials for the production of the products and will also be responsible for the sales, marketing and distribution through their already established dispensary and wholesale channels, which serve more than 50% of Arizona dispensaries. In turn, Panaxia will be responsible for the production, clinical affairs and quality. All products of the joint venture will be sold under the Panaxia brand, of which Nabis owns 50% in Arizona. Under the pact, there is an opportunity for Nabis and Panaxia to expand their joint venture into additional states in the United States. 

READ: Nabis Holdings is building out a portfolio of revenue-generating cannabis assets

“We are excited to partner with Panaxia to develop a variety of new, high quality, pharmaceutical grade products using proven EU GMP standards to meet the evolving needs of our patients,” said Nabis Holdings CEO Shay Shnet.

“This joint venture fits well within our vertically-integrated cannabis portfolio and we look forward to co-creating new innovative products to deliver long-term value to our shareholders as well as our established Arizona customer base of over 36,000 patients and counting,” he added.

Panaxia is currently the largest manufacturer and service provider with home delivery distribution of medical cannabis products in Israel. It is part of the Segal Pharma Group, owned by the Segal family and has been in operation for over 40 years. It manufactures over 600 different pharmaceutical products and distributes them in over 40 countries. Panaxia USA makes over 60 medical cannabis-based products in North America, including sublingual tablets, lozenges, oils, and inhalers designed to treat illnesses such as PTSD, cancer, chronic pain, epilepsy, anorexia, burns, and an assortment of other disorders.

In addition to the US and international cannabis sector, Nabis Holdings invests in assets across multiple industries, including real property, securities and cryptocurrency.

Contact the author Uttara Choudhury at [email protected]

Follow her on Twitter: @UttaraProactive 

Quick facts: Nabis Holdings Inc.

Price: 0.02 CAD

CSE:NAB
Market: CSE
Market Cap: $2.2 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Nabis Holdings Inc. named herein, including the promotion by the Company of Nabis Holdings Inc. in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Buds & Duds: Cannabis stocks reverse; Nabis Holdings jumps after securing...

The North American Marijuana Index, lost 1.5% to 136 points. The OTCQX Cannabis Index dipped 1.4% to 504 points. Buds today were Nabis Holdings Inc (CSE:NAB) (OTCMKTS:NABIF), EuroLife Brands Inc (CSE:EURO) (OTCMKTS:CANVF). Duds were HEXO Corp (TSE:HEXO)...

on 16/10/19

3 min read